MedTrace Logo

Medicaid Incentives for the Prevention of Chronic Diseases: Diabetes Prevention

NCT03139019 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 596

Last updated 2017-05-03

No results posted yet for this study

Summary

The relative effectiveness of incentives based on process (e.g. medication adherence) vs. outcome (improvements in blood pressure) is unknown, leading to the key research question: Which approach is more effective? The incentive structure for this initiative is based on best practices in the use of process and outcome measures to address this fundamental question. A series of incentive designs will be conducted to examine the relative effectiveness of equivalent value incentives based on process (e.g. attending smoking cessation counseling sessions), outcomes (e.g. quitting smoking), or a combination of process and outcomes incentives (e.g. attending smoking cessation counseling sessions and quitting smoking). This will also provide an overarching framework for assessing the relative importance of process versus outcome incentives in different contexts and for different populations.

Conditions

  • Diabetes Prevention

Interventions

BEHAVIORAL

Process incentives

Participants will receive cash based incentives for achieving process based measures (class attendance).

BEHAVIORAL

Outcome incentives

Participants will receive cash based incentives for outcome based measures (weight loss).

BEHAVIORAL

Process and Outcome incentives

Participants will receive cash based incentives for both achieving process based measures (class attendance) and outcome based measures (weight loss).

Sponsors & Collaborators

Principal Investigators

  • Kevin Volpp, MD, PhD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03139019 on ClinicalTrials.gov